GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | December 11, 2024 |
PDB ID | UniProt ID | Title ▲ | Descriptor |
---|---|---|---|
6P8I | P11717 | N-terminal 5 domains of IGFIIR | |
3I8T | Q8K419 | N-terminal CRD1 domain of mouse Galectin-4 in complex with lactose | |
8B97 | B0D650 | N-terminal beta-trefoil lectin domain of the Laccaria bicolor lectin in complex with N-acetyl-lactosamine | |
2WQ4 | B4EH86 | N-terminal domain of BC2L-C Lectin from Burkholderia cenocepacia | |
1OD9 | Q62230 | N-terminal of Sialoadhesin in complex with Me-a-9-N-benzoyl-amino-9-deoxy-Neu5Ac (BENZ compound) | |
3RBU | Q04609 | N-terminally AviTEV-tagged Human Glutamate Carboxypeptidase II in complex with 2-PMPA | |
4TVD | Q8G9Q2 | N-terminally truncated dextransucrase DSR-E from Leuconostoc mesenteroides NRRL B-1299 in complex with D-glucose | |
4TVC | Q8G9Q2 | N-terminally truncated dextransucrase DSR-E from Leuconostoc mesenteroides NRRL B-1299 in complex with gluco-oligosaccharides | |
4TTU | Q8G9Q2 | N-terminally truncated dextransucrase DSR-E from Leuconostoc mesenteroides NRRL B-1299 in complex with isomaltotriose | |
6CKL | P0A0Z8 | N. meningitidis CMP-sialic acid synthetase in the presence of CMP and Neu5Ac2en | |
3CKZ | Q6DPL2 | N1 Neuraminidase H274Y + Zanamivir | |
2HTY | Q6DPL2 | N1 neuraminidase | |
1DZG | P01008 | N135Q-S380C-ANTITHROMBIN-III | |
4GZP | 4GZP | N2 Neuraminidase of A/Tanzania/205/2010 H3N2 in complex with oseltamivir carboxylate | |
4GZW | 4GZW | N2 neuraminidase D151G mutant of A/Tanzania/205/2010 H3N2 in complex with avian sialic acid receptor | |
4GZX | 4GZX | N2 neuraminidase D151G mutant of A/Tanzania/205/2010 H3N2 in complex with human sialic acid receptor | |
4GZT | 4GZT | N2 neuraminidase D151G mutant of A/Tanzania/205/2010 H3N2 in complex with oseltamivir carboxylate | |
4GZS | 4GZS | N2 neuraminidase D151G mutant of a/Tanzania/205/2010 H3N2 in complex with hepes | |
6BR5 | C6KNH8 | N2 neuraminidase in complex with a novel antiviral compound | |
6BR6 | C6KNH8 | N2 neuraminidase in complex with a novel antiviral compound | |
8G40 | 8G40 | N2 neuraminidase of A/Hong_Kong/2671/2019 in complex with 3 FNI19 Fab molecules | |
8G40 | A0A411D019 | N2 neuraminidase of A/Hong_Kong/2671/2019 in complex with 3 FNI19 Fab molecules | |
8G3O | 8G3O | N2 neuraminidase of A/Hong_Kong/2671/2019 in complex with 3 FNI9 Fab molecules | |
8G3O | A0A411D019 | N2 neuraminidase of A/Hong_Kong/2671/2019 in complex with 3 FNI9 Fab molecules | |
8G3V | 8G3V | N2 neuraminidase of A/Hong_Kong/2671/2019 in complex with 4 FNI19 Fab molecules | |
8G3V | A0A411D019 | N2 neuraminidase of A/Hong_Kong/2671/2019 in complex with 4 FNI19 Fab molecules | |
8G3P | A0A411D019 | N2 neuraminidase of A/Hong_Kong/2671/2019 in complex with 4 FNI9 Fab molecules | |
8G3P | 8G3P | N2 neuraminidase of A/Hong_Kong/2671/2019 in complex with 4 FNI9 Fab molecules | |
8G3Q | 8G3Q | N2 neuraminidase of A/Tanzania/205/2010 H3N2 in complex with 3 FNI17 Fab molecules | |
8G3Q | V9SU56 | N2 neuraminidase of A/Tanzania/205/2010 H3N2 in complex with 3 FNI17 Fab molecules | |
8G3M | 8G3M | N2 neuraminidase of A/Tanzania/205/2010 H3N2 in complex with 3 FNI9 Fab molecules | |
8G3M | V9SU56 | N2 neuraminidase of A/Tanzania/205/2010 H3N2 in complex with 3 FNI9 Fab molecules | |
8G30 | 8G30 | N2 neuraminidase of A/Tanzania/205/2010 H3N2 in complex with 4 FNI19 Fab molecules | |
8G30 | V9SU56 | N2 neuraminidase of A/Tanzania/205/2010 H3N2 in complex with 4 FNI19 Fab molecules | |
8G3N | 8G3N | N2 neuraminidase of A/Tanzania/205/2010 H3N2 in complex with 4 FNI9 Fab molecules | |
8G3N | V9SU56 | N2 neuraminidase of A/Tanzania/205/2010 H3N2 in complex with 4 FNI9 Fab molecules | |
4GZO | 4GZO | N2 neuraminidase of A/Tanzania/205/2010 H3N2 in complex with hepes | |
4GZQ | 4GZQ | N2 neuraminidase of A/Tanzania/205/2010 H3N2 in complex with sialic acid | |
8G3R | 8G3R | N2 neuraminidase of A/Tanzania/205/2010 H3N2 with S245N S247T mutations in complex with one FNI17 Fab molecule | |
8G3R | V9SNF2 | N2 neuraminidase of A/Tanzania/205/2010 H3N2 with S245N S247T mutations in complex with one FNI17 Fab molecule | |
3BAX | P04746 | N298S Variant of Human Pancreatic Alpha-Amylase in Complex with Azide | |
3BAY | P04746 | N298S Variant of Human Pancreatic Alpha-Amylase in Complex with Nitrate and Acarbose | |
3BAK | P04746 | N298S mutant of Human Pancreatic Alpha-Amylase in complex with nitrate | |
2HTV | Q6XV46 | N4 neuraminidase | |
2HTW | Q6XV46 | N4 neuraminidase in complex with DANA | |
6LZT | D0XC84 | N409A mutant of chitin-specific solute binding protein from Vibrio harveyi co-crystalized with chitobiose | |
2HT5 | Q07599 | N8 Neuraminidase | |
2HTR | Q07599 | N8 neuraminidase in complex with DANA | |
2HTQ | Q07599 | N8 neuraminidase in complex with zanamivir | |
1NMA | 501094 | N9 NEURAMINIDASE COMPLEXES WITH ANTIBODIES NC41 AND NC10: EMPIRICAL FREE-ENERGY CALCULATIONS CAPTURE SPECIFICITY TRENDS OBSERVED WITH MUTANT BINDING DATA |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024